Cite
HARVARD Citation
Gupta, S. et al. (2016). Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial. Lancet. 3 (1), pp. e13-e22. [Online].